| Sources | Names Used |
|---|---|
| GDSC1000 | MPS-1-IN-1 |
| PharmacoGx | MPS-1-IN-1 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NFATC2 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | PLD6 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | CMPK1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | KIAA1217 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | SKIV2L2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | UFD1L | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | AOAH | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | TMEM97 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | ATXN7L2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | TMEM163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
